Omeres impair tumorigenesis in the INK4aD2/3 cancer-prone mouse. Cell 1999, 97:515?25. 45. HalvorsenOmeres impair tumorigenesis

Omeres impair tumorigenesis in the INK4aD2/3 cancer-prone mouse. Cell 1999, 97:515?25. 45. Halvorsen
Omeres impair tumorigenesis in the INK4aD2/3 cancer-prone mouse. Cell 1999, 97:515?25. 45. Halvorsen TL, Leibowitz G, Levine F: Telomerase activity is sufficient to allow transformed cells to escape from crisis. Mol Cell Biol 1999, 19:1864?1870. 46. Cheng JQ, Jhanwar SC, Klein WM, Bell DW, Lee WC, Altomare DA, et al: p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. Cancer Res 1994, 54:5547?551. 47. Usami N, Sekido Y, Maeda O, Yamamoto K, Minna JD, Hasegawa Y, Nobori T, Olopade OI, Buckler AJ, Testa JR: Beta-catenin inhibits cell growth of a malignant mesothelioma cell line, NCI-H28, PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/29045898 with a 3p21.3 homozygous deletion. Oncogene 2003, 22:7923?930. 48. Petroulakis E, Parsyan A, Dowling RJ, LeBacquer O, Martineau Y, Bidinosti M, Larsson O, Alain T, Rong L, Mamane Y, Paquet M, Furic L, Topisirovic I, Shahbazian D, Livingstone M, Costa-Mattioli M, Teodoro JG, Sonenberg N: p53-dependent translational control of senescence and transformation via 4E-BPs. Cancer Cell 2009, 16:439?46. 49. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR: Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 1994, 211:90?8. 50. Urruticoechea A, Smith IE, Dowsett M: Proliferation marker Ki-67 in early breast cancer. J Clin Oncol 2005, 23:7212?220. 51. Ma C, Rong Y, Radiloff DR, Datto MB, Centeno B, Bao S, Cheng AW, Lin F, Jiang S, Yeatman TJ, Wang XF: Extracellular matrix protein betaig-h3 /TGFBI promotes metastasis of colon cancer by enhancing cell extravasation. Genes Dev 2008, 22:308?21. 52. Ween MP, Lokman NA, Hoffmann P, Rodgers RJ, Ricciardelli C, Oehler MK: Transforming growth factor-beta-induced protein secreted by peritoneal cells increases the metastatic potential of ovarian cancer cells. Intl J Cancer 2011, 128:1570?584. 53. Schneider D, Kleeff J, Berberat, PO, Zhu Z, Korc M, Friess H, and Buchler MW: Induction and expression of BigH3 in pancreatic cancer cells. Biochem. Biophys. ACTA 2002, 1588:1-6. 54. Yamanaka M, Kimura F, Kagata Y, Kondoh N, Asano T, Yamamoto M, and Hayakawa M: BigH3 is overexpressed in clear cell renal cell carcinoma. Oncology Report 2008, 19:865-874. 55. Lin B, Madan A, Yoon JG, Fang X, Yan X, Kim TK, Hwang D, Hood L, Foltz G: Massively parallel signature sequencing and bioinformatics analysis identifies up-regulation of TGFBI and SOX4 in human glioblastoma. PLoS One 2010, 4:e10210.doi:10.1186/1471-2407-12-239 Cite this article as: Li et al.: The role of TGFBI in mesothelioma and breast cancer: association with tumor suppression. BMC Cancer 2012 12:239.Submit your next manuscript to BioMed Central and take full advantage of:?Convenient online submission ?Thorough peer review ?No space constraints or color figure charges ?Immediate publication on acceptance ?Inclusion in PubMed, CAS, Scopus and Google Scholar ?Research which is freely available for redistributionSubmit your manuscript at www.biomedcentral.com/submit
Zhang et al. BMC Cancer 2012, 12:267 http://www.biomedcentral.com/1471-2407/12/RESEARCH ARTICLEOpen AccessTumor suppressor BLU inhibits proliferation of ZM241385 web nasopharyngeal carcinoma cells by regulation of cell cycle, c-Jun N-terminal kinase and the cyclin D1 promoterXiangning Zhang1,2*, Hui Liu1,2, Binbin Li1,2, Peichun Huang1,2, Jianyong Shao3 and Zhiwei He1,2*AbstractBackground: Tumor suppressor genes function to regulate and block tumor cell proliferation. To explore the mechanisms underlying the tumor suppression of BLU/ZMYND10 gene on a frequ.